• Big Pharma’s off-patent drugs lose out in China’s new price-cutting scheme fiercepharma
    December 10, 2018
    In a Battle of Waterloo-style defeat, off-patent drugs from big pharma firms lost major markets in China as the government adopted a novel procurement scheme to slash generic drug costs. But after steep price cuts, local firms aren't considered winners, e
  • Chinese drugmaker pours $145M into plant with plan to produce innovative biologics fiercepharma
    December 06, 2018
    A Chinese maker of heparin, APIs and some finished drugs is launching the second phase of its manufacturing plant, investing nearly $150 million as it moves into producing innovative biologic drugs for the Chinese market.
  • Why China's flu vaccine supply is suffering this season fiercepharma
    December 04, 2018
    It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down, thanks to reduced offering from Sanofi Pasteur..
  • China Opens Door to Foreign Drugs, for a Discount firstwordpharma
    November 28, 2018
    China is approving drugs manufactured by foreign companies at a record pace while extracting sizable discounts, The Wall Street Journal reported.
  • After scandals, China proposes new fines in bid to shore up domestic vaccine industry fiercepharma
    November 28, 2018
    After China’s latest vaccine scandal that resulted in more than a dozen arrests and a $1.3 billion fine for a domestic manufacturer, authorities in the country have rolled out proposals to crack down on future vaccine violations.
  • China proposes new fines for vaccine violations fiercepharma
    November 28, 2018
    After China’s latest vaccine scandal that resulted in more than a dozen arrests and a $1.3 billion fine for a domestic manufacturer, authorities in the country have rolled out proposals to crack down on future vaccine violations.
  • WuXi Biologics Begins Construction of New Facility contractpharma
    November 27, 2018
    WuXi Biologics said that construction of a global innovation center has commenced in the district of Fengxian in Shanghai, China.
  • China gets its first stem cell hospital in Boao biospectrumasia
    November 23, 2018
    Hainan Boao Lecheng International Medical Tourism Pilot Zone, the only one of its kind in China, enjoys nine preferential policies granted by the State Council ever since 2013
  • EISAI launches Lenvima in China biospectrumasia
    November 19, 2018
    In addition to China, LENVIMA is approved for use in the treatment of HCC in Japan, the United States, Europe, and other
  • CASI To Build GMP Mfg. Site In Wuxi, China contractpharma
    November 18, 2018
    CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone in Jiangsu Province, China. The Wuxi Huishan Economic Development Zone is a science and technology innovation cen
PharmaSources Customer Service